NCT03192319View on ClinicalTrials.gov

Optimal Timing of Zoster Vaccine After Hematopoietic Stem Cell Transplantation

NACompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

August 23, 2018

Study Completion Date

August 23, 2018

Conditions
Herpes Zoster
Interventions
BIOLOGICAL

Zostavax

Zostavax will be administrated by subcutaneous injection

Trial Locations (1)

110-744

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT03192319 - Optimal Timing of Zoster Vaccine After Hematopoietic Stem Cell Transplantation | Biotech Hunter | Biotech Hunter